Do you want to read an article? Please log in or register.
Clinical Efficacy and Safety of Icotinib as Adjuvant Therapy for Resected Stage IA Lung Adenocarcinoma: A Real-world Study
Lung Cancer
Related content
Lung Cancer
Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)
Lung Cancer
Hayasaka K, Shimokawa M, Haratake N, Notsuda H, Katsumata S, Hamada A, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Kinoshita I, Takamori S, Muto S, Takanashi Y, Mizuno K, Hayakawa T, Sekihara K, Toda M, Matsuo S, Takegahara K, Hashimoto M, Nakahashi K, Endo M, Ozawa H, Fujikawa R, Tomioka Y, Namba K, Matsubara T, Suzuki J, Watanabe H, Takada K, Hoshino H, Kaiho T, Toyoda T, Shiono S, Soh J, Ohde Y, Okada Y
doi: 10.1016/j.lungcan.2026.108908
Lung Cancer
Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study
Clin Lung Cancer
Gao M, Nie Y, Wang T, Jing F, Zhang F, Tao H, Ma J, Wang L, Hu Y
doi: 10.1016/j.cllc.2025.08.011
Lung Cancer
Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States
Adv Ther
Sankar K, Unni S, Eberl M, Le H, Herrmann T, Gorsh B, Tang M, Coerts F, Ahmed S
doi: 10.1007/s12325-025-03408-z
Lung Cancer
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14
ESMO Open
Frehner L, Schär S, Hayoz S, Guckenberger M, Finazzi T, Mark M, Addeo A, Mauti LA, Betticher D, Stupp R, Curioni-Fontecedro A, Peters S, Früh M, Rothschild SI, Pless M, König D, Opitz I, Ris HB, Özdemir BC, Schmid S
doi: 10.1016/j.esmoop.2025.105870
Lung Cancer
Cost-effectiveness of adjuvant alectinib in the treatment of patients with resected stage IB-IIIA ALK-positive non-small lung cancer in France, based on the ALINA study
Lung Cancer
Supiot R, Gherardi A, du Manoir de Juaye L, Doghri O, Sivignon M, Duruisseaux M, Chouaid C
doi: 10.1016/j.lungcan.2025.108885
RECOMMENDED
Lung Cancer
Chemoimmunotherapy Versus Chemotherapy for Extensive-Stage Small Cell Lung Cancer in the Real-World Setting: Retrospective Study of 904 Patients
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Dimitriou K, Shi S, Marginenau A, Blasi M, Bozorgmehr F, Klotz LV, Eichhorn F, Schneider MA, Allgäuer M, Shah R, Bischoff H, Weykamp F, Stenzinger A, Thomas M, Christopoulos P
doi: 10.1016/j.cllc.2026.06.004
Lung Cancer
Real-World Clinical Outcomes of Concurrent Chemotherapy and Dose-Escalated Twice-Daily Radiotherapy With Simultaneous Integrated Boost (SIB) for Limited-Stage Small Cell Lung Cancer
Clin Lung Cancer
Celikarslan S, Sezen D, Duman M, Durankus NK, Oymak SE, Esen CSB, Rustamov A, Nasir A, Guclu SB, Kanıtez M, Kaban K, Yumuk F, Selcukbiricik F, Mandel NM, Cesur E, Erus S, Tanju S, Dilege S, Gumus T, Atasoy C, Demirkurek C, Falay O, Demirkol O, Bulutay P, Firat P, Atagun Y, Selek U
doi: 10.1016/j.cllc.2026.03.010
Asthma
Long-Term Clinical and Biological Outcomes of Biologic Therapy in Severe Asthma: 24-Month Real-World Cohort Study from Romania
J Clin Med
Mărginean C, Safta AC, Huțanu D, Budin CE, Ianosi MB, Jimborean G, Ianosi ES
doi: 10.3390/jcm15062444
RECOMMENDED
COPD
Real-World Efficacy of BDP/FF/G Fixed Triple Inhalation Powder (NEXThaler) Therapy in the Treatment of Moderate to Severe COPD patients (RESPONSE Study)
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Dulai V, Keglevich A, Sánta B, Abonyi-Tóth Z, Horváth I
doi: 10.1016/j.rmed.2025.108498